High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.

Saved in:
Bibliographic Details
Title: High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster.
Authors: Guirakhoo F; Vaxxinity Inc, Dallas, Texas, USA., Wang S; Vaxxinity Inc, Dallas, Texas, USA., Wang CY; United Biomedical Inc Asia, Hsinchu, Taiwan., Kuo HK; United Biomedical Inc Asia, Hsinchu, Taiwan., Peng WJ; United Biomedical Inc Asia, Hsinchu, Taiwan., Liu H; United Biomedical Inc Asia, Hsinchu, Taiwan., Wang L; Vaxxinity Inc, Dallas, Texas, USA., Johnson M; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Hunt A; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom., Hu MM; Vaxxinity Inc, Dallas, Texas, USA., Monath TP; Vaxxinity Inc, Dallas, Texas, USA., Rumyantsev A; Vaxxinity Inc, Dallas, Texas, USA., Goldblatt D; Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Source: The Journal of infectious diseases [J Infect Dis] 2022 Oct 17; Vol. 226 (8), pp. 1401-1406.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6613
DOI:10.1093/infdis/jiac241